Nisa Investment Advisors LLC trimmed its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 17.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 19,880 shares of the technology company's stock after selling 4,305 shares during the period. Nisa Investment Advisors LLC's holdings in Amdocs were worth $1,829,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. increased its holdings in shares of Amdocs by 16.1% in the 4th quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company's stock valued at $261,756,000 after purchasing an additional 426,035 shares during the period. Wellington Management Group LLP raised its holdings in shares of Amdocs by 25.4% during the fourth quarter. Wellington Management Group LLP now owns 2,680,422 shares of the technology company's stock worth $228,211,000 after acquiring an additional 543,490 shares in the last quarter. Alyeska Investment Group L.P. boosted its position in Amdocs by 86.8% during the fourth quarter. Alyeska Investment Group L.P. now owns 1,681,074 shares of the technology company's stock valued at $143,127,000 after purchasing an additional 781,061 shares during the last quarter. Geode Capital Management LLC grew its stake in Amdocs by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 1,672,193 shares of the technology company's stock valued at $143,262,000 after purchasing an additional 38,460 shares in the last quarter. Finally, Russell Investments Group Ltd. grew its stake in Amdocs by 32.8% in the fourth quarter. Russell Investments Group Ltd. now owns 979,861 shares of the technology company's stock valued at $83,426,000 after purchasing an additional 242,093 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on DOX. Wolfe Research began coverage on Amdocs in a report on Tuesday, July 8th. They set an "outperform" rating for the company. Wall Street Zen raised shares of Amdocs from a "hold" rating to a "buy" rating in a research report on Saturday, June 7th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Amdocs has an average rating of "Buy" and a consensus price target of $105.33.
Get Our Latest Stock Report on DOX
Amdocs Stock Performance
Shares of DOX stock traded up $0.14 during trading on Thursday, reaching $89.31. The company had a trading volume of 453,256 shares, compared to its average volume of 664,323. The firm's 50 day simple moving average is $91.56 and its two-hundred day simple moving average is $88.37. Amdocs Limited has a one year low of $78.61 and a one year high of $95.41. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.16 and a quick ratio of 1.16. The company has a market capitalization of $10.08 billion, a PE ratio of 18.80, a PEG ratio of 1.47 and a beta of 0.52.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The technology company reported $1.78 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.07. The company had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.12 billion. Amdocs had a net margin of 11.39% and a return on equity of 19.52%. The company's quarterly revenue was down 9.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.56 earnings per share. Sell-side analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current year.
Amdocs Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Monday, June 30th will be paid a $0.527 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.36%. Amdocs's payout ratio is presently 44.42%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.